Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study "PRIORITY"

Morten Kofod Lindhardt; Nete Tofte; Marie Frimodt-Møller; Gemma Currie; Christian Delles; Heiko von der Leyen; Harald Mischak; Peter Rossing

Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study "PRIORITY"

Morten Kofod Lindhardt, Nete Tofte, Marie Frimodt-Møller, Gemma Currie, Christian Delles, Heiko von der Leyen, Harald Mischak, Peter Rossing

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Artikelnummer	FR-PO247
Tidsskrift	Journal of the American Society of Nephrology
Vol/bind	30
Sider (fra-til)	498
Antal sider	1
ISSN	1046-6673
Status	Udgivet - okt. 2019
Begivenhed	American Society of Nephrology, kidney week 2019 - Walter E. Washington Convention Center, Washington, USA Varighed: 5 nov. 2019 → 10 nov. 2019 http://asn.19annualmeeting.com/

Konference

Konference	American Society of Nephrology, kidney week 2019
Lokation	Walter E. Washington Convention Center
Land/Område	USA
By	Washington
Periode	05/11/2019 → 10/11/2019
Internetadresse	http://asn.19annualmeeting.com/

Adgang til dokumentet

https://www.asn-online.org/education/kidneyweek/archives/

Citationsformater

Lindhardt, M. K., Tofte, N., Frimodt-Møller, M., Currie, G., Delles, C., von der Leyen, H., Mischak, H., & Rossing, P. (2019). Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study "PRIORITY". Journal of the American Society of Nephrology, 30, 498. Artikel FR-PO247. https://www.asn-online.org/education/kidneyweek/archives/

Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study "PRIORITY". / Lindhardt, Morten Kofod; Tofte, Nete; Frimodt-Møller, Marie et al.
I: Journal of the American Society of Nephrology, Bind 30, FR-PO247, 10.2019, s. 498.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Lindhardt, MK, Tofte, N, Frimodt-Møller, M, Currie, G, Delles, C, von der Leyen, H, Mischak, H & Rossing, P 2019, 'Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study "PRIORITY"', Journal of the American Society of Nephrology, bind 30, FR-PO247, s. 498. <https://www.asn-online.org/education/kidneyweek/archives/>

@article{c4f06a1c1b3040b7b18897df9506b6f0,

title = "Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study {"}PRIORITY{"}",

author = "Lindhardt, {Morten Kofod} and Nete Tofte and Marie Frimodt-M{\o}ller and Gemma Currie and Christian Delles and {von der Leyen}, Heiko and Harald Mischak and Peter Rossing",

year = "2019",

month = oct,

language = "English",

volume = "30",

pages = "498",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "The American Society of Nephrology",

note = "American Society of Nephrology, kidney week 2019, ASN ; Conference date: 05-11-2019 Through 10-11-2019",

url = "http://asn.19annualmeeting.com/",

}

TY - ABST

T1 - Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes

T2 - American Society of Nephrology, kidney week 2019

AU - Lindhardt, Morten Kofod

AU - Tofte, Nete

AU - Frimodt-Møller, Marie

AU - Currie, Gemma

AU - Delles, Christian

AU - von der Leyen, Heiko

AU - Mischak, Harald

AU - Rossing, Peter

PY - 2019/10

Y1 - 2019/10

M3 - Conference abstract in journal

SN - 1046-6673

VL - 30

SP - 498

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

M1 - FR-PO247

Y2 - 5 November 2019 through 10 November 2019

ER -